Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
FibroBiologics, Inc. ( (FBLG) ) has provided an update.
On January 23, 2025, FibroBiologics, Inc. announced that its Compensation Committee and Board of Directors approved the 2024 fiscal year annual incentive bonuses for its executive officers. The updated Summary Compensation Table reveals the total compensation, including bonuses, stock options, and other earnings for the fiscal year ended December 31, 2024. Notably, a bonus of $75,000 was approved for Robert E. Hoffman, the Interim Chief Financial Officer.
More about FibroBiologics, Inc.
YTD Price Performance: -19.40%
Average Trading Volume: 167,904
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $56.33M
Learn more about FBLG stock on TipRanks’ Stock Analysis page.
